A study explored the likelihood of developing schizophrenia following a COVID-19 infection. Results indicate that changes in the immune system caused by COVID-19 could potentially lead to schizophrenia. Based on the examination of schizophrenia’s pathophysiology and etiology, along with the pathogenic mechanisms of SARS-CoV-2, the study suggests a heightened risk of schizophrenia as a long-term consequence of COVID-19. Consequently, it recommends that healthcare professionals prepare to address these potential future risks.

Reference: Pourfridoni M, Askarpour H. COVID-19 and the increase in schizophrenia incidence in the future: A hypothesis and a serious warning. Health Sci Rep. 2022 Dec 5;6(1):e978. doi: 10.1002/hsr2.978. PMID: 36479392; PMCID: PMC9721364.